FGF21 and cardiovascular disorder: The limited available data published, especially as relating to CPHIV, suggest no effect of age upon concentrations of FGF21 or GDF15 over the peripubertal time period when accounting for anemia, diabetes, obesity, or cardiovascular disease [17, 25–27].